GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (XSWX:AFX) » Definitions » Cyclically Adjusted Revenue per Share

Carl Zeiss Meditec AG (XSWX:AFX) Cyclically Adjusted Revenue per Share : CHF0.00 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Carl Zeiss Meditec AG Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Carl Zeiss Meditec AG's adjusted revenue per share for the three months ended in Mar. 2024 was CHF5.098. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Carl Zeiss Meditec AG's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Carl Zeiss Meditec AG was 11.40% per year. The lowest was 6.90% per year. And the median was 9.30% per year.

As of today (2024-06-11), Carl Zeiss Meditec AG's current stock price is CHF174.55. Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was CHF0.00. Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Carl Zeiss Meditec AG was 13.68. The lowest was 4.06. And the median was 7.11.


Carl Zeiss Meditec AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Cyclically Adjusted Revenue per Share Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.63 15.62 11.15 - -

Carl Zeiss Meditec AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio falls into.



Carl Zeiss Meditec AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Carl Zeiss Meditec AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.098/125.0381*125.0381
=5.098

Current CPI (Mar. 2024) = 125.0381.

Carl Zeiss Meditec AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.168 99.543 3.979
201409 3.450 99.823 4.321
201412 3.639 99.543 4.571
201503 3.250 99.717 4.075
201506 3.185 100.417 3.966
201509 3.971 100.417 4.945
201512 3.579 99.717 4.488
201603 3.719 100.017 4.649
201606 3.407 100.717 4.230
201609 3.947 101.017 4.886
201612 3.703 101.217 4.574
201703 4.031 101.417 4.970
201706 3.394 102.117 4.156
201709 4.142 102.717 5.042
201712 3.865 102.617 4.709
201803 4.192 102.917 5.093
201806 4.054 104.017 4.873
201809 4.417 104.718 5.274
201812 4.071 104.217 4.884
201903 4.361 104.217 5.232
201906 4.517 105.718 5.343
201909 5.235 106.018 6.174
201912 4.473 105.818 5.285
202003 4.084 105.718 4.830
202006 3.025 106.618 3.548
202009 4.493 105.818 5.309
202012 4.478 105.518 5.306
202103 4.954 107.518 5.761
202106 5.338 108.486 6.152
202109 5.422 109.435 6.195
202112 4.731 110.384 5.359
202203 5.073 113.968 5.566
202206 5.482 115.760 5.921
202209 6.141 118.818 6.462
202212 5.187 119.345 5.434
202303 5.586 122.402 5.706
202306 5.836 123.140 5.926
202309 6.223 124.195 6.265
202312 5.008 123.773 5.059
202403 5.098 125.038 5.098

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Carl Zeiss Meditec AG  (XSWX:AFX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Carl Zeiss Meditec AG was 13.68. The lowest was 4.06. And the median was 7.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Carl Zeiss Meditec AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (XSWX:AFX) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (XSWX:AFX) Headlines

No Headlines